Trevor Kruder, CEO of Paramount Health Rx and Alpha BioMed Industries, Available for Media Commentary on FDA Compounding Advisory Committee Meeting

Industry leader offers research-backed insights on what the July 23-24 discussions mean for patients, practitioners, and the future of peptide care IRVINE, Calif., July 21, 2026 /PRNewswire/ -- As the U.S. Food and Drug Administration's Pharmacy Compounding Advisory Committee prepares to...